1-4 of 4
Michael A Kelsh, PhD, MPH
Close
Sort by
Journal Articles

Salvage Therapy Outcomes in a Historical Cohort of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Farhad Ravandi, MD, Sherry A. Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, Elias J. Jabbour, MD, Gautam Borthakur, MD, Courtney D. DiNardo, MD MSc, Naval G. Daver, MD, Nicholas J Short, MD, Yesid Alvarado, MD, Jorge E. Cortes, MD, Christopher Kim, PhD, Michael A Kelsh, PhD MPH, MA, Aaron Jacob Katz, PhD PharmD, Richard Williams, MBBS, PhD, Zhao Yang, Bhakti Mehta, MD MPH, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3985.
https://doi.org/10.1182/blood-2018-99-118380
Published: 2018
Journal Articles

A Survey of Oncologist's Opinions and Perceptions Regarding the Use of Granulocyte-Colony Stimulating Factors (G-CSFs) Among Patients Receiving Myelosuppressive Chemotherapy

Alicia Hawkins, Alysa Murphy, BS, Michelle McNamara, BSc, Prasad L Gawade, MBBS, PhD, Rajesh Belani, MD, Michael A Kelsh, PhD MPH, MA
Journal: Blood
Blood (2018) 132 (Supplement 1): 5807.
https://doi.org/10.1182/blood-2018-99-115082
Published: 2018
Journal Articles

Incidence Of Comorbidities In Medicare Beneficiaries Diagnosed With Acute Lymphoblastic Leukemia

Kara Cetin, MPH, Mark Danese, PhD, Aaron J Katz, PharmD, PhD, Michael A Kelsh, PhD, MPH, Michelle Gleeson, PhD, Shilpa S. Alekar, MD, Robert Griffiths, MS, ScD
Journal: Blood
Blood (2013) 122 (21): 4989.
https://doi.org/10.1182/blood.V122.21.4989.4989
Published: 2013
Journal Articles

Patterns Of Care In Medicare Beneficiaries Diagnosed With Acute Lymphoblastic Leukemia

Mark Danese, PhD, Kara Cetin, MPH, Aaron J Katz, PharmD, PhD, Michael A Kelsh, PhD, MPH, Michelle Gleeson, PhD, Robert Griffiths, MS, ScD
Journal: Blood
Blood (2013) 122 (21): 3877.
https://doi.org/10.1182/blood.V122.21.3877.3877
Published: 2013